| dc.creator | Vallejos M,Cristián | |
| dc.creator | Cerda A,Oscar | |
| dc.creator | Valenzuela V,Manuel | |
| dc.creator | Toledo A,Héctor | |
| dc.date | 2003-11-01 | |
| dc.date.accessioned | 2020-02-17T15:31:16Z | |
| dc.date.available | 2020-02-17T15:31:16Z | |
| dc.identifier | https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872003001100014 | |
| dc.identifier.uri | https://revistaschilenas.uchile.cl/handle/2250/129549 | |
| dc.description | Helicobacter pylori is a relevant pathogen for gastroduodenal diseases in human beings. Although its eradication often improves gastroduodenal diseases, H pylori is acquiring an elevated rate of resistance to various antimicrobials, such as metronidazole, clarithromycin, tetracycline and amoxicillin. Multi-drug resistance is a major problem to select the appropriate treatment of infectious diseases. To improve our understanding on the com-plexity of the problem, in this article we review the resistance mechanisms and give an update on H pylori antimicrobial resistance (Rev Méd Chile 2003; 131: 1313-20) | |
| dc.format | text/html | |
| dc.language | es | |
| dc.publisher | Sociedad Médica de Santiago | |
| dc.relation | 10.4067/S0034-98872003001100014 | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.source | Revista médica de Chile v.131 n.11 2003 | |
| dc.subject | Antibiotics | |
| dc.subject | combined | |
| dc.subject | Drug therapy | |
| dc.subject | combinations | |
| dc.subject | Helicobacter pylori | |
| dc.subject | Microbial sensitivity tests | |
| dc.title | Resistencia antimicrobiana en Helicobacter pylori: aspectos clínicos y moleculares | |
